PeptideStack
5.2kquestions
20kanswers
220users

What does a 97.1% purity with a lot-specific certificate attached let me conclude?

Asked 9 Jul 2024Modified 21 months agoViewed 64k times
35

What I have: 97.1% · lot-specific certificate.

This is presented as though it settles something, and I am not convinced it does.

I have two documents that appear to disagree, which is what prompted this.

Which parts of this are informative and which are decoration?

purity
purity

Purity as chromatographic area per cent - the fraction of detected material that is your target peak. It says nothing about how much material is…

833 questions
coa
coa

Certificates of analysis: what fields a useful one carries, how to tell a real analytical report from a marketing document, batch and lot…

771 questions
hplc
hplc

Reverse-phase high-performance liquid chromatography, the workhorse purity method. Column chemistry, mobile-phase choice, gradient slope,…

503 questions
shareeditfollowflag
MM
askedmg_per_ml15k169 Jul 2024
7Same question came up on a different supplier and the answer was entirely about the method. – ivo_paunovic 8 months ago
add a comment

4 Answers

Sorted by votes
34

97.1 per cent is a statement about area, and the other 2.9 per cent is everything the detector saw and did not assign to your peak. Read it as 97.1 of every 100 units of peak area at whatever wavelength was used, not as 97.1 per cent of the mass in the vial. With the lot-specific certificate attached you can at least see how the figure was produced, which is the difference between a measurement and a claim. What it still does not tell you is content: how many milligrams are actually there.

It helps to be literal here: the method matters more than the vial, which is why specifying a method buys you far more than changing suppliers does.

Detection wavelength matters because 214 nm sees the peptide backbone while 280 nm sees only aromatic side chains — so truncation impurities lacking a tryptophan are invisible at 280 nm.

Column pore size affects mass transfer — a 100 Angstrom packing on a 5 kDa peptide restricts diffusion, broadening the peak and potentially hiding small impurities in the shoulders.

I would be careful about over-reading a single measurement — treat it as a data point, not as ground truth.

If you are ranking vendors, specify a method and have all samples tested at the same place.

shareimprove this answerflag
NN
answerednine_point_nine60k14810 Jul 2024
7Confirming from the other direction: I ignored the method section once and paid for it. – Dr_Ilse_Vandenberg 4 months ago
add a comment
Sponsored

PeptideMeter - Independent Peptide Analytics

Aggregated, published test results and vendor ratings built from submitted batches. Methodology stated, dataset browsable, no listing fees.

Browse results
24

More usefully, the single most important distinction is between what purity measures — the fraction of detected material that is your target — and what you actually want to know — how much of the material in the vial is your target.

Gradient slope controls resolution, and gentler slopes resolve co-eluting impurities into separate peaks — so the better method reports the worse purity number.

It helps to be literal here: sample solvent strength affects peak shape — if you inject in strong solvent on a gradient starting in weak solvent, the solvent peak can distort your main peak or create a false shoulder.

The limitation is that single-digit micro-impurities become invisible at typical reporting thresholds, so "no impurities detected" means "none above one in two thousand."

Compare purity within a single laboratory on the same method, never across laboratories.

shareimprove this answerflag
TM
answeredtobias_maartens171k35827 Oct 2024
4Two of us submitted the same lot to different laboratories and got results a tenth apart. – tare_weight 10 months ago
3I would gently push back on the second point — inter-laboratory spread is wider than stated. – tyndall_haze 8 months ago
add a comment
19

Purity is a method-dependent figure, and that is not a limitation of the measurement, it is a property of what the measurement actually answers.

The fraction of your main peak that is actually your target versus isomers, fragments or related sequences is invisible without complementary identity testing.

Integration of the shoulder — whether you use perpendicular drop or tangent skim — determines what area gets assigned to the main peak versus the impurity table.

Inter-laboratory studies on identical peptide material routinely find half-a-per-cent to a full-per-cent spreads in reported purity on the same sample.

The caveat is that purity without identity is only half an answer — a high purity does not mean the peak is actually what you think it is.

The practical summary: ask for the chromatogram and the method, and ignore the headline number until you have both.

shareimprove this answerflag
SG
answeredsinead_gaffney28k372 Aug 2024
16

The short answer is that two competent laboratories on identical material will disagree, and the disagreement is almost always explainable by method differences.

Retention time is sequence-specific and method-specific, so comparing your result to a supplier value using a different method is meaningless without method documentation.

One qualification: achieving purity above roughly 98 per cent on a 30-residue peptide is fighting the chemistry of synthesis, not the quality of the purification.

If you only pay for one test, pay for quantified content. Purity is the number everyone quotes and content is the number that changes what you do.

edited 29 Jul 2024 by ines_brandt — added a caveat about sampling

shareimprove this answerflag
IB
answeredines_brandt113k25722 Jul 2024
Which wavelength was the purity integrated at? It changes the number more than people think. – Dr_Bram_Verhoeven 9 months ago
Does this hold for a longer chain length, where the deletion sequences accumulate? – Dr_Elias_Weiss 8 months ago
add a comment

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.